These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17786365)

  • 1. Analysis of hepatitis C virus-specific CD8+ T-cells with HLA-A*24 tetramers during phlebotomy and interferon therapy for chronic hepatitis C.
    Kaji K; Nakamoto Y; Kaneko S
    Oncol Rep; 2007 Oct; 18(4):993-8. PubMed ID: 17786365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma is produced by CD8 T cells in response to HLA-A24-restricted hepatitis C virus epitopes after sustained virus loss.
    Kobayashi K; Ishii M; Shiina M; Ueno Y; Kondo Y; Kanno A; Miyazaki Y; Yamamoto T; Kobayashi T; Niitsuma H; Kikumoto Y; Takizawa H; Shimosegawa T
    Clin Exp Immunol; 2005 Jul; 141(1):81-8. PubMed ID: 15958073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients.
    Shiina M; Kobayashi K; Kobayashi T; Kondo Y; Ueno Y; Shimosegawa T
    J Gastroenterol; 2006 Aug; 41(8):758-64. PubMed ID: 16988764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.
    Nelson DR; Marousis CG; Ohno T; Davis GL; Lau JY
    Hepatology; 1998 Jul; 28(1):225-30. PubMed ID: 9657116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C.
    Saito H; Ebinuma H; Satoh I; Miyaguchi S; Tada S; Iwabuchi N; Kumagai N; Tsuchimoto K; Morizane T; Ishii H
    J Viral Hepat; 2000 Jan; 7(1):64-74. PubMed ID: 10718945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
    Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
    J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
    Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
    Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.
    Sobao Y; Tomiyama H; Nakamura S; Sekihara H; Tanaka K; Takiguchi M
    Hepatology; 2001 Jan; 33(1):287-94. PubMed ID: 11124847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy.
    Manfras BJ; Weidenbach H; Beckh KH; Kern P; Möller P; Adler G; Mertens T; Boehm BO
    J Clin Immunol; 2004 May; 24(3):258-71. PubMed ID: 15114056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between intrahepatic HCV-specific CTL activity and response to interferon therapy in chronic hepatitis C].
    Tang X; Xu Y; Yuan X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):352-4. PubMed ID: 11986724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
    Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation.
    Gruener NH; Jung MC; Ulsenheimer A; Gerlach JT; Zachoval R; Diepolder HM; Baretton G; Schauer R; Pape GR; Schirren CA
    Liver Transpl; 2004 Dec; 10(12):1487-96. PubMed ID: 15558593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.
    He XS; Rehermann B; López-Labrador FX; Boisvert J; Cheung R; Mumm J; Wedemeyer H; Berenguer M; Wright TL; Davis MM; Greenberg HB
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5692-7. PubMed ID: 10318946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.